138 related articles for article (PubMed ID: 31405785)
1. Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China.
Zhao Z; Peng W; Wu L; Ying B
J Infect Chemother; 2020 Jan; 26(1):63-68. PubMed ID: 31405785
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.
Song J; Liu T; Zhao Z; Hu X; Wu Q; Peng W; Chen X; Ying B
J Clin Lab Anal; 2019 Jun; 33(5):e22880. PubMed ID: 30924187
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.
Nanashima K; Mawatari T; Tahara N; Higuchi N; Nakaura A; Inamine T; Kondo S; Yanagihara K; Fukushima K; Suyama N; Kohno S; Tsukamoto K
Tuberculosis (Edinb); 2012 May; 92(3):253-9. PubMed ID: 22341855
[TBL] [Abstract][Full Text] [Related]
4. Analysis of silent information regulator 1 (SIRT1) gene polymorphisms in antituberculosis- drug-induced hepatotoxicity in a prospective cohort study.
Wang Y; Yan XY; Wu JC; Ji GY; Wu SQ; Huang WW; Chen G; Sandford AJ; He JQ
Int J Clin Pharmacol Ther; 2016 Oct; 54(10):775-81. PubMed ID: 26952036
[TBL] [Abstract][Full Text] [Related]
5. Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study.
Ji GY; Wang Y; Wu SQ; Liu QQ; Wu JC; Zhang MM; Sandford AJ; He JQ
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706680
[TBL] [Abstract][Full Text] [Related]
6. Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity.
Wang Y; Xiang X; Huang WW; Sandford AJ; Wu SQ; Zhang MM; Wang MG; Chen G; He JQ
Sci Rep; 2019 Feb; 9(1):2217. PubMed ID: 30778091
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP2B6 gene polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a Chinese population.
Wang Y; Xiang X; Wu SQ; Chen G; Zhang MM; Wang MG; Wang FJ; Sandford AJ; He JQ
Infect Genet Evol; 2017 Jul; 51():198-202. PubMed ID: 28389387
[TBL] [Abstract][Full Text] [Related]
8. Significance of genetic polymorphisms in long non-coding RNA AC079767.4 in tuberculosis susceptibility and clinical phenotype in Western Chinese Han population.
Zhao Z; Zhang M; Ying J; Hu X; Zhang J; Zhou Y; Zhou Y; Song X; Ying B
Sci Rep; 2017 Apr; 7(1):965. PubMed ID: 28424495
[TBL] [Abstract][Full Text] [Related]
9. Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
Wu S; Wang YJ; Tang X; Wang Y; Wu J; Ji G; Zhang M; Chen G; Liu Q; Sandford AJ; He JQ
PLoS One; 2016; 11(6):e0157478. PubMed ID: 27281183
[TBL] [Abstract][Full Text] [Related]
10. Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.
Yang M; Pan H; Chen H; Liu W; Lu L; He X; Yi H; Tang S
Infect Genet Evol; 2020 Sep; 83():104349. PubMed ID: 32387752
[TBL] [Abstract][Full Text] [Related]
11. CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
Chen R; Wang J; Tang SW; Zhang Y; Lv XZ; Wu SS; Yang ZR; Xia YY; Chen DF; Zhan SY
Int J Tuberc Lung Dis; 2016 Jun; 20(6):812-8. PubMed ID: 27155186
[TBL] [Abstract][Full Text] [Related]
12. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study.
Sun Q; Liu HP; Zheng RJ; Wang P; Liu ZB; Sha W; Xiao HP
Clin Drug Investig; 2017 Dec; 37(12):1125-1136. PubMed ID: 28900877
[TBL] [Abstract][Full Text] [Related]
15. UGT1A1 polymorphisms associated with risk of induced liver disorders by anti-tuberculosis medications.
Chang JC; Liu EH; Lee CN; Lin YC; Yu MC; Bai KJ; Chen HY
Int J Tuberc Lung Dis; 2012; 16(3):376-8. PubMed ID: 22230213
[TBL] [Abstract][Full Text] [Related]
16. Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.
Hu X; Zhang M; Bai H; Wu L; Chen Y; Ding L; Zhao Z; Peng W; Liu T; Song J; Li Y; Lu X; Chen X; Zhou Y; Ying B
Clin Pharmacol Ther; 2018 Aug; 104(2):326-334. PubMed ID: 29071720
[TBL] [Abstract][Full Text] [Related]
17. tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity.
Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Frías A; Visca M; Aidar O; Costa L; de Larrañaga GF
Pharmacogenet Genomics; 2016 Jul; 26(7):357-61. PubMed ID: 27104815
[TBL] [Abstract][Full Text] [Related]
18. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
[TBL] [Abstract][Full Text] [Related]
19. Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity.
Chamorro JG; Castagnino JP; Aidar O; Musella RM; Frías A; Visca M; Nogueras M; Costa L; Perez A; Caradonna F; de Larrañaga GF
Pharmacogenet Genomics; 2017 Oct; 27(10):363-371. PubMed ID: 28799976
[TBL] [Abstract][Full Text] [Related]
20. Is anti-tuberculosis drug-induced hepatotoxicity due to a change in pharmacokinetics caused by alterations in antioxidant gene expression and polymorphisms in the
Ji G; Huang W; He J
Int J Clin Pharmacol Ther; 2020 Feb; 58(2):67-73. PubMed ID: 31670652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
